Immunoglobulin G4 (226-proline

Immunoglobulin G4 (226-proline Uses, Dosage, Side Effects, Food Interaction and all others data.

Immunoglobulin G4 (226-proline is under investigation in clinical trial NCT03946670 (A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).).

Trade Name Immunoglobulin G4 (226-proline
Generic Sabatolimab
Sabatolimab Other Names Anti-tim-3 monoclonal antibody mbg453, Anti-tim3 checkpoint inhibitor mbg453, Immunoglobulin g4 (226-proline,de-c-terminal-lysine), anti-(human hepatitis virus a cellular receptor 2) (human-mus musculus monoclonal clone nvs260714 .gamma.4-chain), disulfide with human-mus musculus monoclonal clone nvs260714 .kappa.-chain, dimer, Immunoglobulin g4-kappa, anti-(homo sapiens havcr2 (hepatitis a virus cellular receptor 2, t-cell immunoglobulin mucin family member 3, tim-3, tim3, timd3, cd366)), humanized monoclonal antibody, Sabatolimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Immunoglobulin G4 (226-proline
Immunoglobulin G4 (226-proline

Innovators Monograph

You find simplified version here Immunoglobulin G4 (226-proline


*** Taking medicines without doctor's advice can cause long-term problems.
Share